One Man’s Fight With Lou Gehrig’s Disease Highlights Why the FDA Needs to Be Reformed
Dying patients simply don’t have the luxury of time, and many American patients with deadly diseases are being prevented from trying drugs that might extend their lives. David’s Story Take, for example, the story of David Huntly, an avid athlete, who was diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. ALS…
Alden Abbott